Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

PEPFAR, the campaign to end H.I.V. globally, would morph into an effort to detect disease outbreaks and sell American products, according to documents obtained by The Times.

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

DAP Health is presenting “Next Gen Care: A Community Conversation on HIV Prevention,” an event that will highlight ...

Last week, the President’s Emergency Plan for AIDS Relief narrowly escaped a devastating $400 million budget cut thanks to Republican Sens. Susan Collins (Maine) and Lisa Murkowski (Alaska), who voted ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn’t cancel the cuts to ...

President Donald Trump is removing a large portion of HIV funding he previously greenlit for a future without AIDs. For ...

This month, the White House released a statement that confirmed Trump “underwent a comprehensive examination” that revealed he had chronic venous insufficiency. Here's what that means, according to ...